These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 6705581)

  • 1. Ketanserin, a serotonin antagonist. Administration in patients with acute respiratory failure.
    Vincent JL; Degaute JP; Domb M; Simon P; Berre J; Vandesteene A
    Chest; 1984 Apr; 85(4):510-3. PubMed ID: 6705581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-HT2-receptor blockade in the treatment of heart failure. A preliminary study.
    Demoulin JC; Bertholet M; Soumagne D; David JL; Kulbertus HE
    Lancet; 1981 May; 1(8231):1186-8. PubMed ID: 6112531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist.
    Wenting GJ; Man in 't Veld AJ; Woittiez AJ; Boomsma F; Schalekamp MA
    Br Med J (Clin Res Ed); 1982 Feb; 284(6315):537-9. PubMed ID: 6800533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of serotonin in patients with acute respiratory failure.
    Huval WV; Lelcuk S; Shepro D; Hechtman HB
    Ann Surg; 1984 Aug; 200(2):166-72. PubMed ID: 6547816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular effects of ketanserin in the treatment of hypertension during coronary artery bypass surgery.
    Richter JA; Barankay A; Göb E; Späth P
    J Cardiovasc Pharmacol; 1986; 8(1):109-15. PubMed ID: 2419672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of 5-hydroxytryptamine in endotoxin-induced respiratory failure of pigs.
    Olson NC
    Am Rev Respir Dis; 1987 Jan; 135(1):93-9. PubMed ID: 3541719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular effects of ketanserin in closed-chest anesthetized dogs.
    van de Water A; Wouters L; Xhonneux R; Reneman S
    Arch Int Pharmacodyn Ther; 1985 Jun; 275(2):267-78. PubMed ID: 3161481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic benefits of 5-hydroxytryptamine inhibition following pulmonary embolism.
    Huval WV; Mathieson MA; Stemp LI; Dunham BM; Jones AG; Shepro D; Hechtman HB
    Ann Surg; 1983 Feb; 197(2):220-5. PubMed ID: 6824376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of ketanserin on central haemodynamics and coronary circulation.
    Hood S; Birnie D; Nasser A; Hillis WS
    J Cardiovasc Pharmacol; 1998 Dec; 32(6):983-7. PubMed ID: 9869505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ketanserin on hemodynamics, plasma-catecholamine concentrations, and serotonin uptake by platelets in volunteers and patients with congestive heart failure.
    Grobecker H; Gessler I; Delius W; Dominiak P; Kees F
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S102-4. PubMed ID: 2412024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of oxygen, nifedipine and ketanserin in hypoxic pulmonary hypertension.
    Hamet A; Král B; Cernohorský D
    Cor Vasa; 1985; 27(6):406-11. PubMed ID: 2936568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of a selective 5-HT2 antagonist, ketanserin, on the pulmonary responses to Escherichia coli endotoxin.
    Ball HA; Parratt JR; Rodger IW
    Br J Pharmacol; 1983 Oct; 80(2):295-301. PubMed ID: 6360280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of ketanserin, a 5-hydroxytryptamine receptor antagonist, for treatment of postoperative hypertension following coronary artery bypass surgery.
    van der Starre PJ; Scheijgrond HW; Reneman RS; Kolling JB
    Anesth Analg; 1983 Jan; 62(1):63-9. PubMed ID: 6600382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic and neurohumoral effects of ketanserin, a 5-HT2 receptor antagonist in patients with congestive heart failure.
    Majid PA; Morris WM; Sole MJ
    Can J Cardiol; 1987 Mar; 3(2):70-4. PubMed ID: 3567710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of dopamine and noradrenaline on cardiovascular function in patients with acute respiratory failure.
    Qvist J; Brynjolf I; Munck O
    Eur J Anaesthesiol; 1994 Mar; 11(2):107-10. PubMed ID: 8174529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute hemodynamic effects of ketanserin in pulmonary hypertension secondary to systemic sclerosis.
    Seibold JR; Molony RR; Turkevich D; Ruddy MC; Kostis JB
    J Rheumatol; 1987 Jun; 14(3):519-24. PubMed ID: 3625632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the antagonists MDL 72222 and ketanserin on responses of cat carotid body chemoreceptors to 5-hydroxytryptamine.
    Kirby GC; McQueen DS
    Br J Pharmacol; 1984 Sep; 83(1):259-69. PubMed ID: 6487893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracerebroventricular serotonin reduces the degree of acute hypoxic ventilatory depression in peripherally chemodenervated rabbits.
    Guner I; Sahin G; Yelmen NK; Aksu U; Oruc T; Yildirim Z
    Chin J Physiol; 2008 Jun; 51(3):136-45. PubMed ID: 18935908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of 5-hydroxytryptamine in the feline response to intravenous infusion of live E. coli.
    Arvidsson S; Falk A; Haglind E; Haglund U
    Br J Pharmacol; 1983 Jul; 79(3):711-8. PubMed ID: 6360276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketanserin: a possible tool for studying the role of serotonin in hypertension.
    Woittiez AJ; Wenting GJ; Man in't Veld AJ; Boomsma F; Schalekamp MA
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S130-6. PubMed ID: 2412035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.